BioScrip Appoints MJ Graves as Interim CFO

BioScrip, a national provider of specialty pharmacy and home care products, has appointed Mary Jane ‘MJ’ Graves, former chief financial officer (CFO) of Critical Homecare Solutions (CHS), which was acquired by BioScrip in 2010, has been appointed interim CFO. David Froesel, Jr has resigned as executive vice president (EVP), CFO and treasurer for personal reasons.

Graves, a certified public accountant (CPA), has nearly 30 years of financial and accounting experience, primarily in the healthcare sector. As the co-founder and managing director of MCG Resources, a financial consulting firm serving healthcare providers and private equity firms, she has been assisting BioScrip with its assessment and has advised other clients in the development and execution of their CFO and finance functions, restructuring plans, financing and operating strategies, and acquisition and divestiture initiatives.

From 2006 until it was sold to BioScrip in 2010, she served as CFO at Critical Homecare Solutions, a start-up home infusion company sponsored by Kohlberg Partners. Prior to that, she served as chief executive officer (CEO) and CFO at Superior Renal Care, a multi-facility outpatient dialysis provider.

Previously, Graves served as president and chief operating officer (COO) at StadtSolutions, a specialty pharmacy. She held various managerial roles at specialty pharmacy, Stadtlander Drug Distribution, including CFO and EVP of operations.


Related reading

New consumer banking head for Citi Asia Pacific